Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Fondazione Telethon has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 distinct examiners and 4 distinct art units, indicating that prosecution is distributed across separate examination assignments.
PENNINGTON, KATIE LEIGH is the busiest listed examiner, with 1 pending matter. Counsel should use matter-specific arguments while coordinating terminology, disclosure positions, and amendment strategy across the biotechnology and pharmaceutical portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PENNINGTON, KATIE LEIGH | 1 | 31.8% | +58.8% |
| CUNNINGCHEN, KATHLEEN MARY | 1 | 62.5% | +60.5% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 47.2% | +63.6% |
| JOHANSEN, PETER N. | 1 | 59.6% | +24.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039734 | Vector | PENNINGTON, KATIE LEIGH | 50d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039734 | Vector | PENNINGTON, KATIE LEIGH | 50d |
| 17614268 | Agents and Methods for Treating Viral Infections | CUNNINGCHEN, KATHLEEN MARY | — |
| 17284160 | SELECTION BY MEANS OF ARTIFICIAL TRANSACTIVATORS | LIPPOLIS, ALEXANDRA ROSE | — |
| 16604484 | GENE THERAPY | JOHANSEN, PETER N. | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| 1646 | 1 |
| 1637 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18039734 | Vector | PENNINGTON, KATIE LEIGH | 1634 | §103§112 | Final Rejection | 50d | Pending | Jun 01, 2023 |
| 17614268 | Agents and Methods for Treating Viral Infections | CUNNINGCHEN, KATHLEEN MARY | 1646 | §103Other | Non-Final OA | — | Pending | Nov 24, 2021 |
| 17284160 | SELECTION BY MEANS OF ARTIFICIAL TRANSACTIVATORS | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Non-Final OA | — | Pending | Apr 09, 2021 |
| 16604484 | GENE THERAPY | JOHANSEN, PETER N. | 1644 | §103 | Non-Final OA | — | Pending | Oct 10, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFondazione Telethon has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Katie Leigh Pennington has the most, with 1 of Fondazione Telethon's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
